Medicinal – Page 67

Overexpression of efflux pump and biofilm associated genes in itraconazole resistant Candida albicans isolates causing onychomycosis

mycolabadmin

This research examines why some fungal infections of the nails resist treatment with the antifungal drug itraconazole. Scientists found that resistant fungi produce more proteins that pump the drug out of their cells (efflux pumps) and form protective biofilm structures. Understanding these resistance mechanisms could help develop better combination treatments that work alongside antifungal drugs to overcome resistance.

Plants, fungi, and antifungals: A little less talk, a little more action

mycolabadmin

Researchers propose looking at how plants communicate with fungi to discover new antifungal medicines. Plants send chemical signals to fungi, and understanding these signals could help us develop better treatments for fungal infections in humans and crops. By studying a simple yeast model, scientists found that plant molecules called strigolactones control fungal phosphate metabolism, suggesting they could become new drug targets.

Arsenic Stress Resistance in the Endophytic Fungus Cladosporium cladosporioides: Physiological and Transcriptomic Insights into Heavy Metal Detoxification

mycolabadmin

A special fungus called Cladosporium cladosporioides, found living inside the roots of Gentiana yunnanensis (a traditional Chinese medicine herb), can tolerate extremely high levels of arsenic. Researchers discovered that this fungus protects itself from arsenic poisoning by storing arsenic mostly in its cell walls, converting toxic arsenic into less harmful forms, and activating its antioxidant defense systems. This discovery could help reduce arsenic contamination in medicinal herbs and lead to new methods for cleaning arsenic-polluted soil.

Enhancement of Mycelial Growth and Antifungal Activity by Combining Fermentation Optimization and Genetic Engineering in Streptomyces pratensis S10

mycolabadmin

Scientists improved a soil bacterium called Streptomyces pratensis S10 that fights a serious wheat disease called Fusarium head blight. They used two strategies: first, they optimized the growth medium using statistical methods to produce more bacteria with stronger antifungal powers, and second, they used genetic engineering to remove a gene that was limiting its disease-fighting ability. The result was a bacteria strain that is much more effective at controlling this crop disease.

Clinical and Genomic Insights into Antifungal Resistance in Aspergillus Isolates from Thailand

mycolabadmin

Researchers in Thailand identified a dangerous fungal infection caused by Aspergillus fumigatus that is resistant to azole antifungal drugs. This is the first time this specific drug-resistant strain has been found in a patient sample in Thailand, though it had been previously detected in environmental samples. The study used genetic testing to understand how the fungus developed resistance and found that it has altered genes that help it survive the antifungal medications commonly used to treat infections.

Population structure in a fungal human pathogen is potentially linked to pathogenicity

mycolabadmin

Aspergillus flavus is a common fungal infection found in both hospitals and the environment. Researchers studied the genetic makeup of 300 fungal samples from patients and the environment across multiple countries. They discovered that clinical isolates cluster into specific genetic groups, with one group containing most patient-derived samples. This finding suggests that certain genetic populations of this fungus may be better adapted to infecting humans than others.

Evaluation of the combined efficacy of inhibitors of heat shock protein 90 and calcineurin with commonly used antifungals against Aspergillus, Rhizopus, and Fusarium isolates

mycolabadmin

Scientists tested combinations of common antifungal medications with special inhibitor drugs that target fungal stress-response systems. When combined, these drugs worked better together against dangerous mold infections like Aspergillus and Rhizopus, especially those that are resistant to standard treatments. The combinations rarely caused harmful interactions and often enhanced the antifungal effects, suggesting this approach could improve treatment of serious mold infections.

Disseminated subcutaneous sporotrichosis in an immunocompetent patient: A case report and a systematic literature review

mycolabadmin

A 74-year-old man developed multiple infected lumps on his arm, wrist, and finger months after being injured by a tree branch. Doctors identified the infection as sporotrichosis caused by a fungus called Sporothrix schenckii using advanced genetic testing. He was successfully treated with itraconazole tablets for several months and completely recovered. This case is unusual because sporotrichosis typically affects people with weakened immune systems, but this patient had a normal immune system.

Candida auris: Outbreak, surveillance and epidemiological monitoring in Northern Greece

mycolabadmin

A dangerous fungus called Candida auris caused an outbreak in hospitals in Northern Greece starting in October 2022. This fungus is particularly concerning because it is resistant to many commonly used antifungal drugs, especially fluconazole. Researchers monitored and tracked the outbreak across multiple hospitals, finding that all cases belonged to the same genetic type (Clade I) and were treatable with certain alternative antifungal medications. The study emphasizes the importance of careful laboratory surveillance and coordinated infection control measures to prevent further spread of this serious infection.

Prevalence and antifungal susceptibility profiles of Candida isolates among patients with candiduria: a multiplex PCR assay

mycolabadmin

Researchers studied urinary tract infections caused by yeast (Candida species) in hospitalized patients. Using advanced molecular testing, they found that while the common yeast Candida albicans was most prevalent, other yeast species were increasingly showing resistance to antifungal medications, particularly to fluconazole. The study highlights the importance of identifying which specific yeast species is causing an infection to choose the most effective treatment.

Research Topic: Medicinal